Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe web page has removed a notice regarding heavy traffic affecting the performance and availability of certain NLM-NCBI services and products.SummaryDifference3%
- Check25 days agoChange DetectedDifference0.9%
- Check32 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check39 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.7%
- Check53 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check61 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.